AXONIXX · UAE · DEEP-TECH HEALTHCARE AI
Simulate life.
Cure sooner.
We build AI world models of the human body — to diagnose earlier, discover drugs faster, and treat disease without medication.
Our approach
We believe medicine's next leap is computational.
Not more data — but higher fidelity models of the body itself.
Systems that reason about biology the way physicists reason about matter.
Live · in-silico
Simulating 1,284,912 synthetic physiological states — right now.
Continuous integration across cardiac, neural, and pharmacokinetic models. Illustrative counter.
Our technologies
Three foundations for a new era of medicine.
Each Axonixx product is built on the same core belief — that simulating biology is the shortest path to healing it.
Why now
A window opens once a generation.
Foundation models made it possible to simulate systems that were once too complex to model at all. Physiology, pharmacology, and neural circuitry now fit inside a computer — and the UAE has the ambition and clarity to build it here.
10⁶
Parameters per simulated patient — resolving physiology at organ-system fidelity.
90%
Of drug candidates fail in human trials. In-silico populations change the odds.
1 in 7
People globally live with migraine. Most therapies still target it with drugs.
Leadership
Operators, scientists, and clinicians — building one system.
Founder & CEO
Abhijit Das
Deep-tech operator building at the frontier of AI, medicine, and neuroscience.
Head of Research
Chief Scientist
Foundation models for physiology, computational biology, and clinical simulation.
Clinical & Regulatory
Chief Medical Officer
Bridging simulation science with clinical validation and global health authorities.
Working with
Work with us